Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products : workshop summary /
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and limitations in the research and clinical trial process i...
| Cote: | Libro Electrónico |
|---|---|
| Auteur principal: | |
| Collectivité auteur: | |
| Autres auteurs: | , |
| Format: | Électronique Actes de congrès eBook |
| Langue: | Inglés |
| Publié: |
Washington, D.C. :
National Academies Press,
[2014]
|
| Sujets: | |
| Accès en ligne: | Texto completo |
Table des matières:
- Introduction
- Identifying and characterizing uncertainty
- The regulators' challenge
- Basic methodologies and applications for understanding and evaluating uncertainty
- Communicating uncertainty
- Final reflections on ways to characterize and communicate uncertainty.


